Relievant Medsystems Receives 2023 Gallup Exceptional Workplace Award
March 30, 2023 09:00 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, March 30, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP),...
Relievant Medsystems Announces Positive Local Coverage Determination by Palmetto GBA for Basivertebral Nerve Ablation in Treating Chronic Vertebrogenic Low Back Pain
March 06, 2023 08:30 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, March 06, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP),...
Relievant Medsystems Announces Formal Coverage Recommendation from NASS for Basivertebral Nerve Ablation as a Treatment for Chronic Vertebrogenic Low Back Pain
February 22, 2023 16:10 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP),...
Relievant Medsystems Announces Highest Quality of Evidence Ranking for Basivertebral Nerve Ablation in ASPN Back Guideline for Interventional Low Back Pain Treatments
January 05, 2023 16:10 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP),...
Relievant Medsystems Announces Updated Policy Statement and Guideline for Basivertebral Nerve Ablation from the International Society for the Advancement of Spine Surgery
November 08, 2022 16:30 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP),...
Relievant Medsystems Receives Most Promising New Product Award for the Intracept Procedure at the 27th Annual Phoenix Conference
October 26, 2022 16:15 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company focused on transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP),...
Relievant Medsystems Announces Publication of ASPN Guidelines on the Diagnosis and Treatment of Vertebrogenic Low Back Pain with Basivertebral Nerve Ablation
September 20, 2022 09:00 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company focused on transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP),...
NBC News’ TODAY Features the Minimally Invasive Intracept® Procedure for Chronic Vertebrogenic Low Back Pain
June 13, 2022 10:30 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, June 13, 2022 (GLOBE NEWSWIRE) -- Relievant Medsystems shared today that the company’s breakthrough chronic low back pain treatment, the Intracept Procedure, was featured on NBC’s TODAY...
Relievant Medsystems Announces New Category I CPT Codes for Intracept® Procedure
January 03, 2022 09:30 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), announced today that new...
Relievant Medsystems Announces Publication of New INTRACEPT Trial Data Demonstrating Long-Term Relief for Chronic Low Back Pain 24 Months Post-Procedure
November 30, 2021 09:30 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced 24-month...